Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
04/2014
04/30/2014CN102083314B PARP inhibitor compounds, compositions and methods of use
04/30/2014CN101945876B Nitrogen-containing bicyclic compounds active on chronic pain conditions
04/30/2014CN101775017B Macrocyclic hepatitis c serine protease inhibitors
04/30/2014CN101633655B Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
04/29/2014US8710239 Process for preparing synthetic intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase involving catalytic asymmetric hydrogenation
04/29/2014US8710057 Imidazo[1,2-B]pyridazine and pyrazolo[1 .5-A]pyrimidine derivatives and their use as protein kinase inhibitors
04/29/2014US8710047 5-HT3 receptor modulators, methods of making, and use thereof
04/29/2014US8710046 5-HT3 receptor modulators, methods of making, and use thereof
04/29/2014CA2632635C Novel inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
04/29/2014CA2619284C Novel crystalline form of a pyridazino [4,5-b] indole derivative
04/24/2014WO2014063061A1 Hydrophobically tagged small molecules as inducers of protein degradation
04/24/2014WO2014062774A1 Pyrazolopyrimidine compounds for the treatment of cancer
04/24/2014WO2014062548A1 Tetrahydroimdidazopyrazine derivatives as cgrp receptor antagonists
04/24/2014WO2014062196A1 Hepatitis c virus inhibitors
04/24/2014WO2014061961A1 Organic electroluminescence compounds and organic electroluminescence device comprising the same
04/24/2014WO2014061693A1 Novel non-aromatic carbocyclic or non-aromatic heterocyclic derivative
04/24/2014WO2014061546A1 Benzindolocarbazole derivative, light-emitting element material produced using same, and light-emitting element
04/24/2014WO2014061031A1 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders
04/24/2014WO2014060962A1 Pemetrexed dipotassium formulations
04/24/2014WO2014060959A1 Crystalline pemetrexed dipotassium process
04/24/2014WO2014060953A1 Process for preparing pemetrexed di potassium and its hydrates
04/24/2014WO2014060432A1 Pyrrolotriazinone derivatives as pi3k inhibitors
04/24/2014WO2014060411A1 Rsv antiviral compounds
04/24/2014WO2014060395A1 Serine/threonine kinase inhibitors
04/24/2014WO2014060112A1 Pyrazolo[4,3-d]pyrimidines as kinase inhibitors
04/24/2014WO2014059902A1 2'-disubstituted substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
04/24/2014WO2014059901A1 2'-cyano substituted nucleoside derivatives and methods of use thereof for treatment of viral diseases
04/24/2014US20140114068 Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
04/24/2014US20140113933 Solid Forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide
04/24/2014US20140113920 Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
04/24/2014US20140113901 Imidazopyridazines as akt kinase inhibitors
04/24/2014US20140113900 Substituted imidazopyridines and the use thereof
04/24/2014US20140113898 Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
04/24/2014US20140113896 Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-c]quinolines
04/24/2014US20140113890 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
04/24/2014US20140113878 Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
04/24/2014US20140112945 Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives
04/23/2014EP2722905A1 Light emitting element material and light emitting element
04/23/2014EP2722334A1 Benzodiazepine bromodomain inhibitor
04/23/2014EP2722333A1 Spiro-indole derivatives for the treatment of parasitic diseases.
04/23/2014EP2721086A1 Materials for organic electroluminescent devices
04/23/2014EP2721032A2 Polyhedral cage-containing metalloporphyrin frameworks, methods of making, and methods of using
04/23/2014EP2721031A2 Bromodomain inhibitors and uses thereof
04/23/2014EP2721030A1 Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives
04/23/2014EP2721028A1 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
04/23/2014EP2721025A1 New selective ccr2 antagonists
04/23/2014CN103748096A Novel pyrrolopyrimidine compounds as inhibitors of protein kinases
04/23/2014CN103748095A Bicyclic heteroaromatic compounds
04/23/2014CN103748094A Tricyclic sulfonamide compounds and methods of making and using same
04/23/2014CN103748088A Inhibitors of bruton's tyrosine kinase
04/23/2014CN103740794A Technology method for preparing active components of chlorella through scale classification
04/23/2014CN103739607A Tri-carbazole multi-arm structural red-light--emitting material and preparation method and application thereof
04/23/2014CN103739606A Environment-friendly synthetic method for 2-amino-5,8-disubstituted-[1,2,4]triazole[1,5-c]pyrimidine
04/23/2014CN103739605A Imaging agents for detecting neurological disorders
04/23/2014CN103739600A A novel method for synthesizing cycle amidine compound
04/23/2014CN103739595A Compounds and compositions as protein kinase inhibitors
04/23/2014CN102766144B Preparation method of indolo[1,2-]quinazoline compound
04/23/2014CN102083814B Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
04/23/2014CN101687827B Aminodihydrothiazine derivatives substituted with cyclic groups
04/22/2014US8703951 Synthesis of 4H-benzo[D]pyrrolo[1,2-A]thiazoles and indolizino[6,7-b]indole derivatives and their use as antitumor therapeutic agents
04/22/2014US8703935 Method of producing a metal phthalocyanine compound, and method of producing a phthalocyanine compound and an analogue thereof
04/22/2014US8703780 Inhibitors of Bruton's tyrosine kinase
04/22/2014US8703779 Preparation of crystalline forms of dihydropyrazolopyrimidinone
04/22/2014US8703778 Heterocyclic kinase inhibitors
04/22/2014US8703777 Certain chemical entities, compositions and methods
04/22/2014US8703504 Membrane-based lateral flow assay devices that utilize phosphorescent detection
04/22/2014US8703116 Modified macromolecule
04/22/2014CA2710194C Inhibitors of p13 kinase
04/22/2014CA2629512C Bicyclic cinnamide compound and prophylactic or therapeutic uses thereof
04/22/2014CA2627623C Methods for inhibiting protein kinases
04/17/2014WO2014059350A1 Open chained or fused 1,1 '-alkylene-bis-uracil derivatives, useful in skin uv-protection
04/17/2014WO2014059314A1 Treating brain cancer using agelastatin a (aa) and analogues thereof
04/17/2014WO2014059095A1 Combinations
04/17/2014WO2014058794A1 Compounds useful for making hcv protease inhibitors
04/17/2014WO2014057684A1 Ladder compound, and organic electroluminescent element using same
04/17/2014WO2014057504A1 Porous crystalline frameworks, process for the preparation therof and their mechanical delamination to covalent organic nanosheets (cons)
04/17/2014WO2014057074A1 Pyrrolobenzodiazepines and conjugates thereof
04/17/2014WO2014057073A1 Pyrrolobenzodiazepines and conjugates thereof
04/17/2014WO2014057072A1 Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
04/17/2014WO2014056953A1 Pyrrolo[3,2-d]pyrimidine derivatives for the treatment of viral infections and other diseases
04/17/2014WO2014056771A1 New pyrrolidine derivatives and their use as acetyl-coa carboxylase inhibitors
04/17/2014WO2014056270A1 Targeting thymidine kinase photosensitizer and pharmaceutical composition and use for cancer treatment thereof
04/17/2014US20140107346 Process for preparing chiral dipeptidyl peptidase-iv inhibitors
04/17/2014US20140107333 Polyhedral cage-containing metalloporphyrin frameworks, methods of making, and methods of using
04/17/2014US20140107137 Ortho-Condensed Pyridine and Pyrimidine Derivatives (e.g., Purines) as Protein Kinases Inhibitors
04/17/2014US20140107128 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
04/17/2014US20140107118 Novel Heterocyclic Derivatives and Their Use in the Treatment of Neurological Disorders
04/17/2014US20140107099 Pyrazolopyrimidine jak inhibitor compounds and methods
04/16/2014EP2719699A1 Certain triazolopyrazines, compositions thereof and methods of use therefor
04/16/2014EP2719698A1 Methods for preparing aurora kinase inhibitors
04/16/2014EP2719395A1 Adsorption of immunopotentiators to insoluble metal salts
04/16/2014EP2718295A1 Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
04/16/2014EP2717877A1 Organic compounds
04/16/2014CN103732597A Tricyclic heterocyclic compounds and JAK inhibitors
04/16/2014CN103732596A Novel pyrrolo pyrimidine derivatives
04/16/2014CN103725034A Method for extracting pigment from Sargassum horneri
04/16/2014CN103725033A Method for extracting Enteromorpha pigment
04/16/2014CN103724356A Fullereneporphyrin derivate photosensitizer as well as preparation method and application thereof
04/16/2014CN103724355A Porphyrin organic small molecular photovoltaic material and preparation method thereof
04/16/2014CN103724354A Method for extracting chlorophyll from radish leaves
1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 573